Vimarsana
Biggest News Aggregation in the World

Page 49 - Cell Stem News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Cell Stem. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Cell Stem Today - Breaking & Trending Today

How microglia contribute to Alzheimer's disease | MIT News | Massachusetts Institute of Technology - Vimarsana News

How microglia contribute to Alzheimer's disease | MIT News | Massachusetts Institute of Technology

A new study from MIT shows how a type of cells called microglia contribute to the slowdown of neuron activity seen in Alzheimer’s disease. The study found that microglia that express the APOE4 gene, one of the strongest genetic risk factors for Alzheimer’s disease, cannot metabolize lipids normally, leading to a buildup of excess lipids that interferes with nearby neurons’ ability to communicate with each other.

Source: mit.edu
How your intestines repair and renew themselves - Vimarsana News

How your intestines repair and renew themselves

New findings show how stem cells coordinate to repair and replace the intestine's lining. The work could clarify disorders like inflammatory bowel disease.

Lymphatic capillaries act as a signaling hub to control intestinal stem cell activity - Vimarsana News

Lymphatic capillaries act as a signaling hub to control intestinal stem cell activity

To act as a robust barrier against pathogens while also absorbing needed nutrients, the lining of the intestines must regenerate on a daily basis to remain equal to the task.

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million - Vimarsana News

Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million

Press release content from Business Wire. The AP news staff was not involved in its creation.

Source: apnews.com
Xilis, Inc.: Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million - Vimarsana News

Xilis, Inc.: Xilis Announces Series A Extension, Bringing Total Round to Over US$89 Million

-- Proceeds will enable Xilis to build its capabilities in supporting biopharma collaborations for drug discovery -- -- Extension led by new investor FPV Ventures -- Xilis, Inc., a pioneering biotechnology